VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
TVGNTevogen Bio Holdings Inc.
$9.82$1.9B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksTVGNEarnings History

TVGN logoTevogen Bio Holdings Inc. (TVGN) Earnings History

Net Loss

4 years of earnings data (2021–2024) · Currently unprofitable on a TTM basis

TTM Net Income
-$31M
● Net Loss
TTM EPS (Diluted)
$-0.16
Per share, diluted
YoY EPS Growth
N/A
Net Margin
N/A
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating MarginN/A
Gross MarginN/A
Return on EquityN/A
Return on Assets-225.6%
Record Annual Net Income$4MFY2022
Record Quarterly EPS$0.05Q4 2022
Consecutive Profitable Years0years
Q3 2025
Net Income-$6M
EPS (Diluted)$-0.03
YoY GrowthN/A
QoQ Growth-4.0%Slow

Loading earnings history...

Tevogen Bio Holdings Inc. (TVGN) Earnings Overview

As of June 23, 2026, Tevogen Bio Holdings Inc. (TVGN) reported trailing twelve-month net income of -$31M. The company earned $-0.16 per diluted share over the past four quarters.

Looking at the long-term picture, TVGN's historical earnings data spans multiple years. The company achieved its highest annual net income of $4M in fiscal 2022.

Tevogen Bio Holdings Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including IMVT (-$506M net income), RCKT (-$209M net income), FATE (-$130M net income, -2051.1% margin), TVGN has comparable earnings metrics. Compare TVGN vs IMVT →

TVGN Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
TVGN logoTVGNCurrent
-$31M$-0.16---—
IMVT logoIMVT
-$506M$-2.48--64.8%-1.5%
RCKT logoRCKT
-$209M$-1.87--60.3%+26.4%
FATE logoFATE
-$130M$-1.08-2051.1%-51.8%+29.9%
TGTX logoTGTX
$462M$2.8972.6%102.8%+1746.7%
ADMA logoADMA
$165M$0.6928.8%35.6%-25.9%
Best in group
Lowest in group

TVGN Historical Earnings Data (2021–2024)

4 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2024-$10M+83.3%-$54M$-0.09--
2023-$60M-1471.9%-$9M$-0.00--
2022$4M+128.3%$-953,083$0.04--
2021-$16M--$5M$-0.33--

Download Data

Export TVGN earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

5+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

TVGN — Frequently Asked Questions

Quick answers to the most common questions about buying TVGN stock.

What is TVGN earnings per share (EPS)?

TVGN trailing twelve-month (TTM) diluted EPS is $-0.16, reflecting N/A year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2021 to 2024 is available in the table on this page.

What is Tevogen Bio Holdings Inc.'s net income?

Tevogen Bio Holdings Inc. (TVGN) trailing twelve-month net income is $-31M as of 2024. Earnings declined N/A year-over-year.

Is TVGN profitable?

TVGN is not currently profitable on a TTM basis, reporting a net loss of $-31M. Net margin is N/A. Investors should monitor for a return to profitability.

What is TVGN's earnings growth rate?

TVGN compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2021 to 2024.

What are TVGN's profit margins?

Tevogen Bio Holdings Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.

Is TVGN growing earnings?

TVGN TTM EPS: $-0.16. Net income: $-31M. YoY earnings change: N/A.

What was TVGN's best earnings year?

Tevogen Bio Holdings Inc.'s highest annual net income on record is $4M, achieved in fiscal year 2022. Earnings history on this page spans 2021 to 2024 and includes all annual and quarterly figures.

What were TVGN's earnings last quarter?

TVGN's most recent reported quarter was Q3 2025. Net income was $-6M with diluted EPS of $-0.03. For a full breakdown of all quarters, see the quarterly earnings table on this page.

TVGN Earnings Over Time (2021–2024)

Net income & EPS — annual and quarterly view